Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?

Claudio Viegas Jr; Carlos A Manssour Fraga; Maria Emilia Sousa; Andrea Tarozzi

doi:10.3389/fphar.2020.609274

Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?

Front Pharmacol. 2020 Dec 9:11:609274. doi: 10.3389/fphar.2020.609274. eCollection 2020.

Authors

Claudio Viegas Jr¹, Carlos A Manssour Fraga², Maria Emilia Sousa³, Andrea Tarozzi⁴

Affiliations

¹ Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
² Faculty of Pharmacy, University of Porto, Porto, Portugal.
³ Department for Life Quality Studies, University of Bologna, Bologna, Italy.
⁴ Laboratory of Research in Medicinal Chemistry (PeQuiM), Federal University of Alfenas, Alfenas, Brazil.

No abstract available

Keywords: Alzheirmer's disease; Huntington (disease); Parkinsion’s disease; amyotrofic lateral sclerosis; neurodegenaration; neurodegenerative diseases; neurodenegerative disorders; oxidative stress.

Publication types

Editorial